IL143994A0 - Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells - Google Patents

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Info

Publication number
IL143994A0
IL143994A0 IL14399499A IL14399499A IL143994A0 IL 143994 A0 IL143994 A0 IL 143994A0 IL 14399499 A IL14399499 A IL 14399499A IL 14399499 A IL14399499 A IL 14399499A IL 143994 A0 IL143994 A0 IL 143994A0
Authority
IL
Israel
Prior art keywords
growth hormone
human growth
stem cells
hematopoietic stem
pluripotent hematopoietic
Prior art date
Application number
IL14399499A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL143994A0 publication Critical patent/IL143994A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14399499A 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells IL143994A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
IL143994A0 true IL143994A0 (en) 2002-04-21

Family

ID=8233268

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14399499A IL143994A0 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Country Status (15)

Country Link
US (1) US20060029581A1 (https=)
EP (3) EP1016413A1 (https=)
JP (1) JP4808316B2 (https=)
AT (1) ATE342064T1 (https=)
AU (2) AU772222B2 (https=)
BR (1) BR9916726A (https=)
CA (1) CA2354194A1 (https=)
CY (1) CY1107603T1 (https=)
DE (1) DE69933581T2 (https=)
DK (1) DK1140149T3 (https=)
ES (1) ES2275359T3 (https=)
IL (2) IL143994A0 (https=)
PT (1) PT1140149E (https=)
SI (1) SI1140149T1 (https=)
WO (1) WO2000040260A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
CA2417356A1 (en) 2000-08-01 2002-02-07 Yissum Research Development Company Directed differentiation of embryonic cells
ES2380009T3 (es) * 2001-07-31 2012-05-07 Genzyme Global S.A.R.L. Métodos para movilizar las células madre/progenitoras
CA2540529C (en) * 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
JP2013515081A (ja) * 2009-12-21 2013-05-02 アンブルックス，インコーポレイテッド 修飾されているブタのソマトトロピンポリペプチドおよびそれらの使用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
DE69430059T2 (de) * 1993-06-15 2002-11-14 British Biotech Pharmaceuticals Ltd., Cowley Freisetzung und Mobilisierung hämatopoietischer Zellen
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
EP0871458B1 (en) * 1995-07-21 2002-11-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
EP0877795A4 (en) * 1996-01-16 2003-03-05 Depuy Orthopaedics Inc INSULATION OF PROCUREMENT CELLS FROM HEMATOPOIETIC AND NON-HEMATOPOIETIC TISSUES AND THEIR USE
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DE69919969T2 (de) * 1998-12-17 2005-09-29 Applied Research Systems Ars Holding N.V. Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
JP2003535144A (ja) * 2000-06-07 2003-11-25 アプライド・リサーチ・システムズ・エイアールエス・ホールディング・ナムローゼ・フェンノートシャップ 多能性造血幹細胞の流動を刺激するヒト成長ホルモン
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
WO2000040260A1 (en) 2000-07-13
AU2103900A (en) 2000-07-24
JP2002534393A (ja) 2002-10-15
US20060029581A1 (en) 2006-02-09
JP4808316B2 (ja) 2011-11-02
DE69933581T2 (de) 2007-06-21
AU2004203355B2 (en) 2007-05-17
EP1140149B1 (en) 2006-10-11
AU772222B2 (en) 2004-04-22
EP1779865A1 (en) 2007-05-02
ATE342064T1 (de) 2006-11-15
EP1016413A1 (en) 2000-07-05
SI1140149T1 (sl) 2007-02-28
DK1140149T3 (da) 2007-02-19
IL143994A (en) 2009-06-15
CY1107603T1 (el) 2013-03-13
AU2004203355A1 (en) 2004-08-19
DE69933581D1 (de) 2006-11-23
EP1140149A1 (en) 2001-10-10
BR9916726A (pt) 2001-09-11
CA2354194A1 (en) 2000-07-13
PT1140149E (pt) 2007-01-31
ES2275359T3 (es) 2007-06-01

Similar Documents

Publication Publication Date Title
IL147990A0 (en) Multipotent adult stem cells and methods for isolation
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
WO2001021766A8 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
IL188472A (en) Method for generating endoderm cells from human pluripotent stem cells
AU2003209259A8 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
WO2003029418A3 (en) Proliferation and differentiation of stem cells using extracellular matrix and other molecules
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
GB0400570D0 (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
SG147437A1 (en) Crystalline form of gamma-aminobutyric acid analog
WO2003018751A3 (en) Apparatus and method for electroporation of biological samples
MXPA03000257A (es) Composiciones para el cuidado de la piel que contienen elastomeros de silicon.
WO2003027247A3 (en) Modulation of stem cells using zinc finger proteins
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
ATE348876T1 (de) Verfahren zur vermehrung von natürlichen killerzellen
GB9925964D0 (en) Hair transplantation
TNSN05166A1 (en) Isolating ingredients from biological material
WO2002083888A3 (en) The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
DE60037007D1 (de) Angereicherte zentralnervensystem-zellpopulationen
WO2004044127A3 (en) Stem cell populations
WO2005037219A3 (en) Disinfecting teat care compositions
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2002033043A3 (en) Method and marker for the isolation of human multipotent hematopoietic stem cells
WO2003062197A3 (en) Nek2 inhibitors